UBS Group’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Sell |
122,310
-29,973
| -20% | -$31.8K | ﹤0.01% | 5767 |
|
|
2025
Q1 | $166K | Sell |
152,283
-123,181
| -45% | -$134K | ﹤0.01% | 5419 |
|
|
2024
Q4 | $416K | Buy |
275,464
+96,598
| +54% | +$146K | ﹤0.01% | 4812 |
|
|
2024
Q3 | $267K | Buy |
178,866
+93,963
| +111% | +$140K | ﹤0.01% | 4497 |
|
|
2024
Q2 | $138K | Sell |
84,903
-48,721
| -36% | -$78.9K | ﹤0.01% | 4818 |
|
|
2024
Q1 | $227K | Buy |
133,624
+5,756
| +5% | +$9.79K | ﹤0.01% | 4630 |
|
|
2023
Q4 | $396K | Sell |
127,868
-15,813
| -11% | -$49K | ﹤0.01% | 4144 |
|
|
2023
Q3 | $882K | Buy |
143,681
+45,962
| +47% | +$282K | ﹤0.01% | 3183 |
|
|
2023
Q2 | $612K | Buy |
97,719
+8,075
| +9% | +$50.6K | ﹤0.01% | 3675 |
|
|
2023
Q1 | $428K | Sell |
89,644
-194,744
| -68% | -$929K | ﹤0.01% | 3814 |
|
|
2022
Q4 | $2.47M | Buy |
284,388
+164,543
| +137% | +$1.43M | ﹤0.01% | 2391 |
|
|
2022
Q3 | $1.43M | Sell |
119,845
-230,465
| -66% | -$2.74M | ﹤0.01% | 2596 |
|
|
2022
Q2 | $4.99M | Buy |
350,310
+161,299
| +85% | +$2.3M | ﹤0.01% | 1775 |
|
|
2022
Q1 | $3.94M | Buy |
189,011
+60,104
| +47% | +$1.25M | ﹤0.01% | 2119 |
|
|
2021
Q4 | $2.98M | Buy |
128,907
+32,869
| +34% | +$759K | ﹤0.01% | 2547 |
|
|
2021
Q3 | $2.86M | Buy |
96,038
+94,956
| +8,776% | +$2.83M | ﹤0.01% | 2479 |
|
|
2021
Q2 | $37K | Sell |
1,082
-11,857
| -92% | -$405K | ﹤0.01% | 5647 |
|
|
2021
Q1 | $426K | Buy |
12,939
+10,413
| +412% | +$343K | ﹤0.01% | 4050 |
|
|
2020
Q4 | $155K | Buy |
2,526
+1,955
| +342% | +$120K | ﹤0.01% | 4431 |
|
|
2020
Q3 | $20K | Buy |
+571
| New | +$20K | ﹤0.01% | 5443 |
|